Pivot Bio
PrivateLast Round
Series D
Jul 19, 2021
Est. Valuation
$2B
Total Funding Raised
$616.85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pivot Bio is an agricultural biotechnology company that develops microbial nitrogen fertilizers to replace synthetic alternatives, allowing farmers to cultivate crops that naturally capture atmospheric nitrogen, thereby lowering farming costs and promoting environmental sustainability.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Environmental Monitoring
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pivot Bio Comparables
Compare Pivot Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sound Agriculture | 83% | |
| Verdesian Life Sciences | 78% | |
| Azotic Technologies Limited | 78% |
Pivot Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jul 19, 2021 | ||||
| Series C | Apr 30, 2020 | ||||
| Series B | Oct 2, 2018 | ||||
| Series A | Mar 24, 2016 | ||||
| Seed | Oct 30, 2014 | ||||
Grant | Oct 1, 2011 |
Key People
Founding team and executive leadership
Pivot Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RCM | Series D |
| Hercules Capital | Series D |
| Bunge Ventures | Series D, Series C |
| Temasek | Series B, Series D, Series C |
| Codon Capital | Series B, Series C |
| Prelude Ventures | Series A, Series D, Series C |
| Tekfen Ventures | Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 45% MoM, reaching 24.2K.
- Apr 29, 2026
Opened a new office in Hazelwood, Missouri.
Recent news
Latest coverage and updates
- attends_eventSep 1, 2026
Pivot Bio attended event 2026 Farm Progress Show on Sep 1st '26.
- closes_offices_inAug 28, 2026
Pivot Bio closed offices in California, United States, Northern America, Americas on Jan 1st '26.
- recognized_asJul 24, 2026
Pivot Bio recognized as Best Inventions.
Pivot Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pivot Bio's valuation, stock price, and market status.
Is Pivot Bio a public or private company?
Pivot Bio is a private company.
What is the current stock price of Pivot Bio?
Pivot Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Pivot Bio worth (valuation)?
Pivot Bio's valuation is estimated at $2.0B based on funding round data.
Can I buy Pivot Bio stock?
Pivot Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pivot Bio's last funding round?
Pivot Bio's most recent funding round was Series D on July 19, 2021.
Who are the main investors in Pivot Bio?
Key investors in Pivot Bio include Temasek, Breakthrough Energy Ventures, Breakthrough Energy Foundation, Energy Ventures, Breakthrough Energy Discovery.
Will Pivot Bio IPO soon?
No public IPO plans have been announced for Pivot Bio.
How can I track Pivot Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pivot Bio's secondary market activity and sign up for updates.